SURGICAL INNOVATIONS GROUP PLC

Share Issue/Capital Change • Feb 28, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5114R

Surgical Innovations Group PLC

28 February 2019

28 February 2019

Surgical Innovations Group plc

("Surgical Innovations" or "the Company")

Exercise of Options & Total Voting Rights

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 5,000,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by certain employees of the Company. Application will be made to the London Stock Exchange for admission of the 5,000,000 ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 6 March 2019.               

Total Voting Rights

Following Admission, the Company will have 787,566,177 ordinary Shares in issue with each share carrying the right to one vote. The Company has no ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 787,566,177.

For further information contact:

Surgical Innovations Group Plc	www.sigroupplc.com
Nigel Rogers, Executive Chairman	Tel: +44 (0)113 230 7597
Melanie Ross, COO and CFO
Walbrook PR (Financial PR & Investor Relations)	Tel: +44 (0)20 7933 8780 or si@walbrookpr.com
Paul McManus	Mob: +44 (0)7980 541 893
Lianne Cawthorne	Mob: +44 (0)7584 391 303
N+1 Singer (Nominated Adviser and Broker)	+44 (0)20 7496 3000
Richard Lindley
Rachel Hayes

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUWAWRKNAUUAR